MARKET

GCVRZ

Sanofi FR
GCVRZ
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
0.3341
0.0258
0.0165
1,088,892,353.18
Regeneron/ Sanofi say FDA has delayed Dupixent COPD label
Seeking Alpha · 05/31 10:49
Third human bird flu case found in U.S.
Seeking Alpha · 05/30 17:46
Moderna nearing deal to win U.S. funding for bird flu vaccine trial: FT
Seeking Alpha · 05/30 11:04
Evercore says biotech ‘winter is finally thawing’
Seeking Alpha · 05/14 15:24
Novavax’s sudden rise burns short sellers: report
Seeking Alpha · 05/11 11:59
AI-discovered drugs have an 80%–90% success rate: study
Seeking Alpha · 05/10 18:13
Novavax Ditches 'Going Concern,' Embraces Sanofi Safety Net (Rating Upgrade)
Seeking Alpha · 05/10 17:50
Novavax hits a 52-week high as Sanofi deal prompts J.P. Morgan upgrade
Seeking Alpha · 05/10 15:15
More

Webull offers Sanofi FR stock information, including NASDAQ: GCVRZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GCVRZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GCVRZ stock methods without spending real money on the virtual paper trading platform.